SNAPC5: A Protein Linked to various Diseases and Potential Drug Targets

Target Name: SNAPC5

NCBI ID: G10302

SNAPC5

SNAPC5: A Protein Linked to various Diseases and Potential Drug Targets

SNAPC5, also known as Small Nuclear RNA-Activating Complex Polypeptide 5, is a protein that is expressed in various tissues and cells of the human body. It plays a crucial role in the regulation of gene expression and has been linked to a number of diseases , including cancer. As a result, SNAPC5 has become a focus of interest for researchers as a potential drug target or biomarker.

The SNAPC5 protein is composed of 214 amino acid residues and has a molecular weight of 24 kDa. It is located in the nucleus and is involved in the regulation of gene expression by binding to specific DNA sequences. SNAPC5 has been shown to play a role in the regulation of various gene expression pathways, including those involved in cell growth, apoptosis, and inflammation.

One of the key functions of SNAPC5 is its ability to activate small nuclear RNA (snRNA), which is a type of RNA molecule that plays a critical role in regulating gene expression. SNAPC5 has been shown to interact with snRNA and to activate its translation into protein. This process is regulated by a number of factors, including the concentration of available resources, such as amino acids and energy.

The regulation of gene expression by SNAPC5 is also involved in the control of cell signaling pathways. SNAPC5 has been shown to be involved in the regulation of several signaling pathways, including the NF-kappa pathway and the NF-kappa-B pathway. These pathways are involved in the regulation of cell growth, differentiation, and inflammation, and are important for the development and maintenance of various tissues and organs.

In addition to its role in gene expression and cell signaling, SNAPC5 is also involved in the regulation of DNA replication. SNAPC5 has been shown to interact with the protein DNMT, which is involved in the regulation of DNA replication and repair. This interaction between SNAPC5 and DNMT suggests that SNAPC5 may be involved in the regulation of gene expression and DNA replication.

SNAPC5 has also been shown to play a role in the regulation of cellular aging and stress. Aging and stress can cause a number of cellular changes, including an increase in the production of reactive oxygen species (ROS) and the activation of pathways involved in cellular stress. SNAPC5 has been shown to be involved in the regulation of these processes and may be a potential target for therapies aimed at preventing or treating aging and stress-related diseases.

In conclusion, SNAPC5 is a protein that is involved in a number of important cellular processes and has been linked to a number of diseases. As a result, it has become a focus of interest for researchers as a potential drug target or biomarker. Further research is needed to fully understand the role of SNAPC5 in these processes and to develop effective therapies aimed at targeting it.

Protein Name: Small Nuclear RNA Activating Complex Polypeptide 5

Functions: Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box

The "SNAPC5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNAPC5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets